Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
---|
CEO | Mr. Peter Anevski CPA |
IPO Date | Oct. 25, 2019 |
Location | United States |
Headquarters | 1359 Broadway |
Employees | 563 |
Sector | Health Care |
Industries |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Past 5 years
USD 21.00
USD 28.76
USD 9.36
USD 11.18
USD 16.93
USD 10.74
USD 3.92
USD 26.12
USD 31.47
USD 4.15
USD 5.90
USD 210.86
USD 15.44
StockViz Staff
January 15, 2025
Any question? Send us an email